News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
403,925 Results
Type
Article (27083)
Company Profile (66)
Press Release (376776)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (111241)
Career Advice (504)
Deals (18877)
Drug Delivery (52)
Drug Development (50750)
Employer Resources (50)
FDA (12613)
Job Trends (8891)
News (197932)
Policy (20194)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1822)
Accelerated approval (3)
Adcomms (9)
Allergies (71)
Alliances (27646)
ALS (60)
Alzheimer's disease (846)
Antibody-drug conjugate (ADC) (54)
Approvals (12680)
Artificial intelligence (171)
Autoimmune disease (11)
Automation (4)
Bankruptcy (156)
Best Places to Work (7268)
BIOSECURE Act (6)
Biosimilars (45)
Biotechnology (45)
Bladder cancer (54)
Brain cancer (19)
Breast cancer (201)
Cancer (1489)
Cardiovascular disease (123)
Career advice (448)
Career pathing (13)
CAR-T (69)
Cell therapy (208)
Cervical cancer (16)
Clinical research (43087)
Collaboration (471)
Compensation (269)
Complete response letters (9)
COVID-19 (1555)
CRISPR (13)
C-suite (144)
Cystic fibrosis (49)
Data (1569)
Decentralized trials (2)
Denatured (17)
Depression (31)
Diabetes (185)
Diagnostics (3735)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (57)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (56)
Earnings (42136)
Editorial (19)
Employer branding (7)
Employer resources (47)
Events (55203)
Executive appointments (471)
FDA (13624)
Featured Employer (19)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (446)
Gene editing (39)
Generative AI (10)
Gene therapy (140)
GLP-1 (449)
Government (3118)
Grass and pollen (3)
Guidances (39)
Healthcare (12859)
Huntington's disease (11)
IgA nephropathy (17)
Immunology and inflammation (41)
Indications (20)
Infectious disease (1640)
Inflammatory bowel disease (80)
Inflation Reduction Act (4)
Influenza (33)
Intellectual property (50)
Interviews (50)
IPO (8468)
IRA (19)
Job creations (1952)
Job search strategy (415)
Kidney cancer (7)
Labor market (10)
Layoffs (184)
Leadership (4)
Legal (3800)
Liver cancer (60)
Lung cancer (238)
Lymphoma (101)
Machine learning (2)
Management (18)
Manufacturing (125)
MASH (49)
Medical device (13001)
Medtech (13004)
Mergers & acquisitions (10742)
Metabolic disorders (451)
Multiple sclerosis (55)
NASH (11)
Neurodegenerative disease (53)
Neuropsychiatric disorders (12)
Neuroscience (1189)
NextGen: Class of 2025 (4123)
Non-profit (2997)
Northern California (1458)
Now hiring (16)
Obesity (229)
Opinion (80)
Ovarian cancer (53)
Pain (62)
Pancreatic cancer (58)
Parkinson's disease (95)
Partnered (11)
Patents (116)
Patient recruitment (79)
Peanut (38)
People (35392)
Pharmaceutical (18)
Pharmacy benefit managers (11)
Phase I (12397)
Phase II (18723)
Phase III (15281)
Pipeline (742)
Policy (62)
Postmarket research (1760)
Preclinical (4001)
Press Release (19)
Prostate cancer (76)
Psychedelics (19)
Radiopharmaceuticals (168)
Rare diseases (207)
Real estate (2993)
Recruiting (17)
Regulatory (14781)
Reports (18)
Research institute (1655)
Resumes & cover letters (59)
Rett syndrome (2)
RNA editing (2)
RSV (21)
Schizophrenia (53)
Series A (69)
Series B (49)
Service/supplier (4)
Sickle cell disease (27)
Southern California (1295)
Special edition (3)
Spinal muscular atrophy (106)
Sponsored (14)
Startups (2224)
Stomach cancer (9)
Supply chain (39)
Tariffs (11)
The Weekly (8)
United States (13801)
Vaccines (379)
Venture capitalists (16)
Weight loss (147)
Women's health (17)
Worklife (4)
Date
Last 7 days (382)
Last 30 days (1382)
Last 365 days (20373)
2025 (6093)
2024 (21694)
2023 (24523)
2022 (32735)
2021 (35049)
2020 (34007)
2019 (29967)
2018 (23008)
2017 (20157)
2016 (19098)
2015 (22358)
2014 (16830)
2013 (13794)
2012 (15006)
2011 (15318)
2010 (13782)
Location
Africa (375)
Alabama (17)
Alaska (2)
Arizona (122)
Arkansas (10)
Asia (25518)
Australia (4131)
California (3339)
Canada (1277)
China (371)
Colorado (168)
Connecticut (192)
Delaware (118)
Europe (51462)
Florida (572)
Georgia (127)
Idaho (35)
Illinois (370)
India (16)
Indiana (241)
Iowa (3)
Japan (122)
Kansas (78)
Kentucky (14)
Louisiana (8)
Maine (28)
Maryland (649)
Massachusetts (2408)
Michigan (108)
Minnesota (272)
Mississippi (2)
Missouri (58)
Montana (19)
Nebraska (18)
Nevada (32)
New Hampshire (60)
New Jersey (1148)
New Mexico (9)
New York (1013)
North Carolina (710)
North Dakota (4)
Northern California (1458)
Ohio (137)
Oklahoma (5)
Oregon (24)
Pennsylvania (866)
Puerto Rico (7)
Rhode Island (25)
South America (566)
South Carolina (21)
Southern California (1295)
Tennessee (78)
Texas (566)
Utah (120)
Virginia (87)
Washington D.C. (43)
Washington State (277)
West Virginia (3)
Wisconsin (43)
403,925 Results for "c5 medical werks".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Sunstone Therapies to participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference
Sunstone Therapies, a leader in the delivery of psychedelic-assisted therapy in the medical setting and the development and execution of clinical trials, announces that Manish Agrawal MD, Co-founder and CEO, will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference.
June 20, 2024
·
1 min read
Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 5, 2025
March 6, 2025
·
3 min read
Press Releases
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - March 5, 2025
March 6, 2025
·
1 min read
Press Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - March 5, 2025
March 5, 2025
·
2 min read
Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2025
February 6, 2025
·
3 min read
Pharm Country
MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Mind Medicine announced today that members of the Company’s management team will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference being held on June 27, 2024.
June 21, 2024
·
1 min read
Clene to Present at H.C. Wainwright’s 5th Annual Neuro Perspectives Virtual Conference
Clene Inc. today announced that management will present at H.C. Wainwright’s 5th Annual Neuro Perspective Virtual Conference and host 1x1 investor meetings.
June 24, 2024
·
1 min read
Pharm Country
atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference
atai Life Sciences today announced that the Company’s management team will participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference taking place on June 27, 2024.
June 26, 2024
·
1 min read
Pharm Country
Over 5,000 Procedures Completed in U.S. with Centinel Spine’s prodisc® C Vivo and prodisc C SK Cervical Total Disc Replacement System
Centinel Spine®, LLC, the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement technology platform in the world, announced the completion of the 5,000th case in the U.S. with the prodisc C Vivo and prodisc C SK Cervical TDR System.
April 16, 2024
·
3 min read
Press Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2025
February 5, 2025
·
2 min read
1 of 40,393
Next
